Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Marianna Trani"'
Autor:
Monica Giannotta, Sara Benedetti, Francesco Saverio Tedesco, Monica Corada, Marianna Trani, Rocco D'Antuono, Queensta Millet, Fabrizio Orsenigo, Beatriz G Gálvez, Giulio Cossu, Elisabetta Dejana
Publikováno v:
EMBO Molecular Medicine, Vol 6, Iss 2, Pp 239-258 (2013)
Abstract Muscular dystrophies are severe genetic diseases for which no efficacious therapies exist. Experimental clinical treatments include intra‐arterial administration of vessel‐associated stem cells, called mesoangioblasts (MABs). However, on
Externí odkaz:
https://doaj.org/article/13f779a9d01541e48c7e6a4abf3a1738
Autor:
Marianna Trani, Roberto Gianni-Barrera, Valentin Djonov, Ruslan Hlushchuk, Christian Fontanellaz, Andrea Banfi, Michael Heberer
Publikováno v:
Angiogenesis
Gianni-Barrera, Roberto; Trani, Marianna; Fontanellaz, Christian; Heberer, Michael; Djonov, Valentin; Hlushchuk, Ruslan; Banfi, Andrea (2013). VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting. Angiogenesis, 16(1), pp. 123-36. Dordrecht: Springer Netherlands 10.1007/s10456-012-9304-y
Gianni-Barrera, Roberto; Trani, Marianna; Fontanellaz, Christian; Heberer, Michael; Djonov, Valentin; Hlushchuk, Ruslan; Banfi, Andrea (2013). VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting. Angiogenesis, 16(1), pp. 123-36. Dordrecht: Springer Netherlands 10.1007/s10456-012-9304-y
Therapeutic over-expression of vascular endothelial growth factor (VEGF) can be used to treat ischemic conditions. However, VEGF can induce either normal or aberrant angiogenesis depending on its dose in the microenvironment around each producing cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da9b1c7de0ad8c86eba2a40298c6482
http://doc.rero.ch/record/310927/files/10456_2012_Article_9304.pdf
http://doc.rero.ch/record/310927/files/10456_2012_Article_9304.pdf
Autor:
Petra Korpisalo‐Pirinen, Marianna Trani, Elena Groppa, Andrea Uccelli, Sime Brkic, Silvia Reginato, Manuele G. Muraro, Veronica Sacchi, Galina Wirth, Roberto Gianni-Barrera, Seppo Ylä-Herttuala, Andrea Banfi, Maria Filippova, Boris Dasen
Publikováno v:
EMBO Reports
Vascular endothelial growth factor (VEGF) is the master regulator of angiogenesis, whose best‐understood mechanism is sprouting. However, therapeutic VEGF delivery to ischemic muscle induces angiogenesis by the alternative process of intussusceptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f3a87281f91186648c4ce2d53a4a1c7
Publikováno v:
Developmental Cell
Developmental Cell; Vol 26
Developmental Cell; Vol 26
VE-cadherin is a component of endothelial cell-to-cell adherens junctions, and it has a key role in the maintenance of vascular integrity. During embryo development, VE-cadherin is required for the organization of a stable vascular system, and in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8582df4e5d9abd946d68d18cf39cfc27
Publikováno v:
Biochemical Society transactions
Therapeutic angiogenesis is an attractive strategy to treat patients suffering from peripheral or coronary artery disease. VEGF (vascular endothelial growth factor-A) is the fundamental factor controlling vascular growth in both development and postn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::919f046d43ce2791d6909de06aeb249c
Publikováno v:
Scopus-Elsevier
It has been recently demonstrated that small gold compounds could have a potential anti-tumoral activity. Here, we report that aurothiomalate (ATM), a gold compound already used in clinical therapy for the treatment of rheumatoid arthritis, has a pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::535f5863f99e281fa7ae70dcc139f005
https://doi.org/10.4161/cc.8.2.7596
https://doi.org/10.4161/cc.8.2.7596
Autor:
Elisabetta Dejana, Marianna Trani
Publikováno v:
Current opinion in hematology. 22(3)
PURPOSE OF REVIEW The control of the endothelial barrier function is essential for vascular homeostasis and is mainly mediated by cell-to-cell junctions that tightly regulate permeability to plasma solutes and circulating cells such as leukocytes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ab888a69af9bc2ef29d1e1202ed704
https://pubmed.ncbi.nlm.nih.gov/25767951
https://pubmed.ncbi.nlm.nih.gov/25767951
Autor:
Elena Groppa, Veronica Sacchi, Sime Brkic, Marianna Trani, Michael Heberer, Roberto Gianni-Barrera, Andrea Banfi
Publikováno v:
Circulation. 130
Vascular Endothelial Growth Factor-A (VEGF) is the master regulator of vascular growth and it can induce either normal or aberrant angiogenesis depending on its dose in the microenvironment around each producing cell in vivo, and not on the total amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c939d11510c2c09b60f6ca97d1eca613
https://doi.org/10.1161/circ.130.suppl_2.18332
https://doi.org/10.1161/circ.130.suppl_2.18332
Autor:
Michael Heberer, Roberto Gianni-Barrera, Lorenz Gürke, Abdulsamie Patel, Marianna Trani, Andrea Banfi, Edin Mujagic, Thomas Wolff
Publikováno v:
Human gene therapy methods
Human Gene Therapy Methods
Human Gene Therapy Methods
Therapeutic angiogenesis by vascular endothelial growth factor (VEGF) gene delivery is an attractive approach to treat ischemia. VEGF remains localized around each producing cell in vivo, and overexpression of mouse VEGF(164) (mVEGF(164)) induces nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62735047c3d8d0125791e8287751722b
https://pubmed.ncbi.nlm.nih.gov/23360398
https://pubmed.ncbi.nlm.nih.gov/23360398
Publikováno v:
Biochemical Society Transactions; Dec2011, Vol. 39 Issue 6, p1644-1648, 5p